Horizon Medicare Blue Rx Enhanced 2026 Medicare Part D Plan
Horizon Medicare Blue Rx Enhanced is a 2026 Medicare Part D (PDP) plan from Horizon Blue Cross Blue Shield of New Jersey. It provides prescription drug coverage, with pricing determined by premiums, deductibles, and medication tiers.
Updated: .
| Horizon Medicare Blue Rx Enhanced: Part D Plan Overview | |
|---|---|
| Part D Plan ID: | S5993-003 |
| Plan Year: | 2026 |
| Total Part D Premium: | $139.10 |
| Annual Deductible: | $200.00 |
| Part D Benefit Type: | Enhanced |
| No Deductible Drug Tier: | Yes |
| Low Income Subsidy: | Yes |
| Insured By: | Horizon Blue Cross Blue Shield of New Jersey |
Plan Drug Costs
In addition to the monthly premium, Horizon Medicare Blue Rx Enhanced may include a deductible and tier-based cost-sharing for medications. The sections below outline how prescription drug costs are applied under this plan.
Monthly Premium
The 2026 Medicare Part D plan Horizon Medicare Blue Rx Enhanced includes a monthly premium. The table below outlines the premium amount for this plan.
| Basic Part D Premium: | $116.20 |
| Supplemental Part D Premium: | $22.90 |
| Total Part D Premium: | $139.10 |
| Low Income Premium Subsidy: | $54.17 |
| Low Income Premium Subsidy CMS Pays: | $54.20 |
| Low Income Subsidy Premium: | $84.90 |
Eligible beneficiaries may qualify for the Low-Income Subsidy (LIS), or “Extra Help,” to lower prescription drug costs. Learn more on the Social Security Extra Help page.
Annual Deductible
The annual deductible for Horizon Medicare Blue Rx Enhanced is $200.00. You are responsible for this cost before the plan shares prescription drug expenses.
Prescription Drug Cost Sharing
Cost-sharing for Horizon Medicare Blue Rx Enhanced is based on drug tiers, with copayments or coinsurance applied to each tier. The table below summarizes typical out-of-pocket costs.
| Drug Tier | Retail | Mail Order | |
|---|---|---|---|
| Preferred Generic | $0.00 | $0.00 | |
| Generic | $8.00 | $8.00 | |
| Preferred Brand | $40.00 | $40.00 | |
| Non-Preferred Drug | 45.00% | 45.00% | |
| Specialty Tier | 33.00% | 0.00% | |
| *Deductible does not apply. | |||
CMS Star Ratings
Medicare Part D plans are rated from 1 to 5 stars by CMS, based on quality and performance. Higher ratings indicate stronger overall results. The table below displays the rating for Horizon Medicare Blue Rx Enhanced.
| CMS Measure | Star Rating |
|---|---|
| Overall Plan Rating | |
| Drug Plan Customer Service | |
| Complaints and Changes in the Drug Plan | |
| Member Experience with the Drug Plan | |
| Drug Safety and Accuracy of Drug Pricing |
Contact Information for Horizon Blue Cross Blue Shield of New Jersey
| Website: | Horizon Blue Cross Blue Shield of New Jersey Plan Page |
|---|---|
| Formulary: | Horizon Blue Cross Blue Shield of New Jersey Formulary Page |
| Pharmacy: | Horizon Blue Cross Blue Shield of New Jersey Pharmacy Page |
| Prospective Part D Members: | (888)765-7134 |
| Prospective Part D TTY Users: | 711 |
- CMS.gov, Landscape Source Files — Last accessed June 13, 2026
- CMS.gov, Medicare Part C & D Performance — Last accessed June 13, 2026
- CMS.gov, Plan Benefits Package — Last accessed June 13, 2026
- CMS.gov, Monthly Enrollment by Contract/Plan/State/County — Last accessed June 13, 2026
Data sources and methodology documentation..
- Horizon Blue Cross Blue Shield of New Jersey (official source), http://www.horizonblue.com/Medicare — Last accessed April 27, 2026
- Medicare.gov, "Explore your Medicare coverage options" — Last accessed May 2, 2026
- Medicare.gov, "What's Medicare Drug Coverage (Part D)?" — Last accessed May 1, 2026
- CMS.gov, "Understanding True Out-of-Pocket (TrOOP) Costs" — Last accessed May 1, 2026
MedicarePlans.com operates as an independent, non-government informational resource and is not affiliated with or endorsed by the U.S. Government or the federal Medicare program.
Data provenance documentation is maintained in alignment with the U.S. Core Data for Interoperability (USCDI) Provenance standard.
Page content independently curated and maintained by David W. Bynon, Editorial Steward, using a standardized, data-driven methodology for accurate, non-commercial Medicare plan interpretation and resolution.